Cis element 'decoy' against the upstream promoter of the human estrogen receptor gene

L Penolazzi1, E Lambertini, G Aguiari

  • 1Dipartimento di Biochimica e Biologia Molecolare, Università degli Studi di Ferrara, Via L. Borsari, 46 44100, Ferrara, Italy.

Insights

Estrogen receptor (ER)-negative breast cancers lack ER gene expression. Researchers identified a specific DNA sequence that binds negative transcription factors, inhibiting ER gene expression in these cancers.

Area of Science:

  • Molecular Biology
  • Oncology
  • Genetics

Background:

  • Estrogen receptor (ER)-negative breast carcinomas are associated with poor prognosis and resistance to endocrine therapy.
  • The molecular mechanisms underlying the lack of ER gene expression in these tumors remain incompletely understood.
  • Identifying factors that regulate ER gene expression is crucial for developing targeted therapies.

Purpose of the Study:

  • To investigate the potential role of negative transcription factors in suppressing ER gene expression in ER-negative breast cancer cells.
  • To identify specific DNA sequences within the ER gene promoter that interact with these putative negative factors.
  • To explore the possibility of reactivating ER gene expression in ER-negative cells.

Main Methods:

  • Analysis of the P3 upstream promoter of the human ER gene.
  • Identification and characterization of a specific DNA sequence (-3258 to -3157) that binds proteins from ER-negative MDA-MB-231 cells.
  • Introduction of this DNA sequence as 'decoy' cis elements into ER-negative breast cancer cells.
  • Transient transfection assays using SV-40 promoted luciferase reporter.
  • Gel shift assays and Southwestern experiments to identify DNA-protein interactions and specific proteins.

Main Results:

  • A critical DNA sequence in the ER gene promoter (-3258 to -3157) was identified that binds protein factors present in ER-negative MDA-MB-231 cells.
  • This sequence was shown to inhibit ER gene transcription.
  • Introduction of the DNA sequence as a 'decoy' element reactivated ER gene transcription in ER-negative cells.
  • The identified sequence decreased SV-40 promoted luciferase activity in transfection assays.
  • Gel shift and Southwestern assays confirmed specific DNA-protein interactions and the presence of a protein unique to ER-negative MDA-MB-231 cells.

Conclusions:

  • A novel regulatory mechanism involving negative transcription factors and a specific DNA sequence in the ER gene promoter contributes to ER gene silencing in ER-negative breast cancer.
  • The identified 'decoy' cis element strategy shows potential for reactivating ER gene expression, offering a new therapeutic avenue for ER-negative breast cancers.

Related Concept Videos

The Eukaryotic Promoter Region02:40

The Eukaryotic Promoter Region

The eukaryotic promoter region is a segment of DNA located upstream of a gene. It contains an RNA polymerase binding site, a transcription start site, and several cis-regulatory sequences.  The proximal promoter region is located in the vicinity of the gene and has cis-regulatory sequences and the core promoter. The core promoter is the binding site for RNA polymerase and is usually located between -35 and +35 nucleotides from the transcription start site. The distal promoter regions are...
Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Internal Receptors01:56

Internal Receptors

Many cellular signals are hydrophilic and therefore cannot pass through the plasma membrane. However, small or hydrophobic signaling molecules can cross the hydrophobic core of the plasma membrane and bind to internal, or intracellular, receptors that reside within the cell. Many mammalian steroid hormones use this mechanism of cell signaling, as does nitric oxide (NO) gas.
RNA Polymerase II Accessory Proteins02:36

RNA Polymerase II Accessory Proteins

Proteins that regulate transcription can do so either via direct contact with RNA Polymerase or through indirect interactions facilitated by adaptors, mediators, histone-modifying proteins, and nucleosome remodelers. Direct interactions to activate transcription is seen in bacteria as well as in some eukaryotic genes. In these cases, upstream activation sequences are adjacent to the promoters, and the activator proteins interact directly with the transcriptional machinery. For example, in...